| For: | Ji XZ, Liu ZD, Ye YP, Li Q, Liu XJ, Zhou MH, Jin Y. Advanced Lung Adenocarcinoma with EGFR 19-del Mutation Transformed into SCC after EGFR-tyrosine Kinase inhibitors Treatment: A Case report. World J Clin Cases 2024; 12(20): 4405-4411 [PMID: 39015891 DOI: 10.12998/wjcc.v12.i20.4405] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i20/4405.htm |
| Number | Citing Articles |
| 1 |
Guo-Qiang Song, Tian-li He, Ke-jie Ji, Yi-meng Duan, Guo-qiang Hu. Treatment decision-making for leptomeningeal metastasis after TKI resistance in EGFR-mutant lung cancer: a comprehensive review on staging, resistance patterns, and multimodal interventions. Frontiers in Neurology 2026; 17 doi: 10.3389/fneur.2026.1737679
|
| 2 |
Mengli Qiu, Peiwen Guo, Jieheng Lin, Sisi Wang, Wenping Wang, Jianying Yang, Zhongming Huang, Yang Cao. A Rare Histologic Transformation from EGFR-Positive Lung Adenocarcinoma to EGFR-Negative Squamous Cell Carcinoma After EGFR-TKIs Resistance: A Case Report. OncoTargets and Therapy 2025; doi: 10.2147/OTT.S513879
|
| 3 |
Ruo-Bing Qi, Zheng-Hao Wu. Advanced lung adenocarcinoma with <i>EGFR</i> 19-del mutation transforms into squamous cell carcinoma after <i>EGFR</i> tyrosine kinase inhibitor treatment. World Journal of Clinical Cases 2024; 12(32): 6543-6546 doi: 10.12998/wjcc.v12.i32.6543
|